RM

Robert Maxey

Merck: 7 patents #1,604 of 9,382Top 20%
Genentech: 1 patents #1,597 of 2,392Top 70%
MD Merk Sharp & Dohme: 1 patents #1 of 28Top 4%
Overall (All Time): #568,176 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
9981916 Pyridazine derivatives as RORc modulators Monique Bodil van Niel, Andrew Peter Cridland, Benjamin Fauber, Alberto Gobbi, Christopher Hurley +3 more 2018-05-29
7592456 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists Mark Stuart Chambers, Neil Roy Curtis, Emanuela Gancia, Myra Gilligan, Alexander Humphries +2 more 2009-09-22
7176203 Imidazo-triazine derivatives as ligands for gaba receptors Mark Stuart Chambers, Simon Charles Goodacre, David Hallett, Michael Geoffrey Neil Russell, Leslie Joseph Street 2007-02-13
7144887 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition Helen Jane Bryant, Mark Stuart Chambers, Philip Jones, Angus Murray MacLeod 2006-12-05
7094777 5-HT2A receptor ligands Mark Stuart Chambers, Neil Roy Curtis, Angus Murray MacLeod, Helen Jane Szekeres 2006-08-22
7030128 Imidazo-pyrimidine derivatives as ligands for GABA receptors Wesley Blackaby, Jose Luis Castro Pineiro, Mark Stuart Chambers, Simon Charles Goodacre, David Hallett +5 more 2006-04-18
6900209 Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition Mark Stuart Chambers, Philip Jones, Angus Murray MacLeod, Helen Jane Szekeres 2005-05-31
6730681 Triazolo-pyrimidine derivatives as ligands for gaba receptors Mark Stuart Chambers, Ian Collins, Simon Charles Goodacre, David Hallett, Philip Jones +2 more 2004-05-04
6316468 Phenylindole derivatives as 5-HT2A receptor antagonists Michael Rowley, Monique Bodil Van Niel 2001-11-13